FDA Inspection 830397 — Edward M. Kerwin, M.D
The FDA completed an inspection of Edward M. Kerwin, M.D on October 17, 2012 in Medford, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 17, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Medford, OR (United States)
Additional Details
Clinical Investigator (CI)